|Benchmarking and Quality Best Practices
Best Practices, LLC has conducted extensive research in the field of Benchmarking and Quality. Browse through and sample our published Benchmarking and Quality research in the topics below:
| || |
|Strategic KOL Management: Coordination, Software and Thought Leader Identification|
Non-members: Click here to review a complimentary excerpt from "Strategic KOL Management: Coordination, Software and Thought Leader Identification"
In the face of changes in the regulatory and access landscape, pharmaceutical organizations can no longer afford to have multiple functions and regions blindly contacting the same Key Opinion Leader (KOL). For any number of reasons – efficiency and courtesy are two obvious ones – organizations should have a KOL management system that ensures coordinated interactions. An organization's CRM software clearly plays a role in this.
Best Practices, LLC conducted this research to help organizations create and maintain a strategic KOL management system. In particular, this study examines current approaches to coordination, software and thought leader identification for a strategic KOL management system. This study provides an evidence-based understanding of current and evolving approaches to creating and maintaining an integrated, strategically-focused KOL management system.
Coordinating and Communicating Strategic Thought Leader Management and Engagement
Aligning Software Tools to Support Strategic Thought Leader Management and Engagement
Identifying and Engaging Thought Leaders
Functional areas that conduct strategic KOL management activities (across indicated product lifecycle periods)
Most effective approaches to coordination of KOL management activities
Communication channels your organization uses to share best practices across the organization
Frequency of nonfield-based strategic KOL management staff interactions with KOLs
Software programs/systems utilized by your organization
Do you utilize a system with a global line of sight for all KOL activities
Involvement level of MSLs in KOL identification
Importance rating of 8 KOL services
KOL activities most valued by organization
SAMPLE KEY FINDING
Respondents recognized the importance having a platform for sharing learning/best practices among the staff involved in strategic KOL management. Almost half of respondents said they use quarterly in-person meetings while nearly a third utilize an online database/spreadsheet.
Thirty-four TL management leaders from 29 biopharma and device organizations participated in the external field survey, and we interviewed 4 participants for in-depth insights
Preparing Medical Science Liaison Teams for a Changing Environment: Value and Budget
Non-members: Click here to review a complimentary excerpt from "Preparing Medical Science Liaison Teams for a Changing Environment: Value and Budget"
Their interactions with thought leaders have made Medical Science Liaisons an important part of biopharmaceutical companies' clinical programs. Best Practices, LLC conducted this benchmarking study to provide leading insights on the value associated with MSLs’ responsibilities and how MSL team budgets are allocated. This study captures wide-ranging insights and metrics that will help Medical Affairs leaders to demonstrate the value of their MSL teams and to compare their budget allocations with peers in the industry. Companies can use this study to improve the effectiveness of their Medical Science Liaison teams.
Medical Liaisons: Leadership and Value
Medical Liaisons: Resources and Budget
SAMPLE KEY METRICS
Medical science liaisons leadership
Value associated with Medical science liaison responsibilities for mature and emerging markets
Level of outsourcing at MSL teams
Factors affecting annual MSL team budgets
Breakdown of MSL team budget at mature and emerging markets
SAMPLE KEY FINDING
Value Associated with Medical Science Liaisons’ Responsibilities: Internal stakeholders find value in responsibilities related to medical communication with key influencers and internal support for sales & marketing activities. While perceived value for medical communication with external stakeholders is seen as high, there is less perceived value for the internal support for sales & marketing among internal stakeholders.
This study engaged executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Twenty three participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of seven participants from Brazil, India and other Asia markets. This report includes Mature and Emerging Markets segments’ analysis.
Effective Thought Leader Management: Leadership, Relationships and Technology
Non-members: Click here to review a complimentary excerpt from "Effective Thought Leader Management: Leadership, Relationships and Technology"
With so many of its activities affecting new product development and performance, medical affairs is recognized as one of the most important functions within pharma organizations. Thought leader management is one of the critical responsibilities of medical affairs groups because companies look to thought leaders to inform and guide clinical programs.
Some of the key components of an effective thought leader management program include its leadership structure and approach to relationship development. Best Practices LLC performed this research study to identify how leading pharma companies structure and organize their thought leader management organizations, to examine the drivers of thought leader management relationships and to highlight new technologies used to maintain relationships.
The benchmark data in this study will help companies find better ways to create effective thought leader management strategies that will enhance and inform a critical aspect of an organization’s operations. This document includes mature and emerging markets segment analysis.
Benchmark Participant Demographics
Scope, Structure and Leadership
SAMPLE KEY METRICS
Number of products involving thought leaders
Title of person with oversight responsibility for thought leader management
Group with primary oversight for thought leader management
Drivers of thought leader management program
Importance rating of activities tied to developing thought leader relationships
Importance rating of activities tied to maintaining thought leader relationships
Value rating of various new technologies used for thought leader interactions in mature markets
Value rating of various new technologies used for thought leader interactions in emerging markets
SAMPLE KEY FINDING
Number of and Interaction Frequency with thought leader s are the Most Important Management Criteria: Within 86% of the mature market companies and all of the emerging market companies number of thought leaders and frequency of interaction with thought leaders drive thought leader management initiatives.
MSL Interactions and Clinical Trials Drive TL Relationship Development: In 70% of the mature market segment and 57% of the emerging market segment, MSL interactions is key to thought leader relationship development. In addition, 68% of the mature market and 86% of the emerging market segment reported that Funding Clinical Research is vital for building thought leader relationships.
Forty survey responses from Medical Affairs leaders at 32 pharmaceutical and medical device companies in the mature market and Emerging Markets. This report captures insights on both Mature and emerging market segments.